Target type: biologicalprocess
The directed movement of substances into, out of or within a lysosome. [GOC:ai]
Lysosomal transport is a complex process involving the delivery of macromolecules, organelles, and cellular debris to lysosomes for degradation. This process is essential for maintaining cellular homeostasis and preventing the accumulation of harmful substances.
**1. Sorting and Packaging:**
* Materials destined for lysosomes are first sorted and packaged into transport vesicles within the Golgi apparatus.
* This process involves the recognition of specific sorting signals on the target molecules by adaptor proteins.
**2. Vesicle Budding and Transport:**
* Once packaged, these transport vesicles bud off from the Golgi and travel towards the lysosomes.
* Motor proteins and microtubules within the cytoskeleton guide the vesicles along their path.
**3. Fusion with Early Endosomes:**
* Upon reaching the lysosomal pathway, transport vesicles fuse with early endosomes, which are small, membrane-bound organelles responsible for sorting and processing incoming material.
* The early endosome functions as a sorting hub, separating different cargo for delivery to various destinations.
**4. Maturation into Late Endosomes:**
* The early endosome then matures into a late endosome, gradually acidifying and acquiring hydrolytic enzymes.
* These enzymes, such as proteases, lipases, and nucleases, are responsible for breaking down the various components of the incoming material.
**5. Fusion with Lysosomes:**
* Finally, the late endosome fuses with a lysosome, a larger, more acidic organelle containing a complete set of hydrolytic enzymes.
* This fusion event creates a hybrid compartment where the degradation process takes place.
**6. Degradation and Recycling:**
* Inside the lysosome, the hydrolytic enzymes break down the incoming material into smaller molecules, such as amino acids, fatty acids, and sugars.
* These degradation products can be recycled back into the cytoplasm for use in other cellular processes.
**7. Autophagy:**
* Lysosomes are also involved in autophagy, a process that allows cells to degrade and recycle their own components.
* During autophagy, damaged organelles or portions of the cytoplasm are encapsulated in double-membrane vesicles called autophagosomes.
* These autophagosomes then fuse with lysosomes for degradation.
**8. Lysosomal Disorders:**
* Dysfunctional lysosomal transport can lead to a variety of inherited diseases, known as lysosomal storage disorders.
* These diseases arise from the accumulation of undigested material in lysosomes due to defects in specific hydrolytic enzymes or transport proteins.
* Examples include Pompe disease, Tay-Sachs disease, and Gaucher disease.
Lysosomal transport is a highly regulated process that plays a vital role in maintaining cellular homeostasis. Its intricate mechanisms ensure the efficient and timely delivery and degradation of cellular cargo, contributing to the overall health and function of the cell.'
"
Protein | Definition | Taxonomy |
---|---|---|
Proprotein convertase subtilisin/kexin type 9 | A proprotein convertase subtilisin/kexin type 9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8NBP7] | Homo sapiens (human) |
Heat shock 70 kDa protein 1A | A heat shock 70 kDa protein 1A that is encoded in the genome of human. [PRO:DAN, UniProtKB:P0DMV8] | Homo sapiens (human) |
Prosaposin | A prosaposin that is encoded in the genome of human. [PRO:DNx, UniProtKB:P07602] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
adenosine diphosphate | Adenosine Diphosphate: Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. | adenosine 5'-phosphate; purine ribonucleoside 5'-diphosphate | fundamental metabolite; human metabolite |
adenosine | quinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlit | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
8-aminoadenosine | |||
s 1033 | (trifluoromethyl)benzenes; imidazoles; pyridines; pyrimidines; secondary amino compound; secondary carboxamide | anticoronaviral agent; antineoplastic agent; tyrosine kinase inhibitor | |
fenretinide | 4-hydroxyphenyl retinamide : A retinoid obtained by formal condensation of the carboxy group of all-trans retinoic acid and the anilino group of 4-hydroxyaniline. Synthetic retinoid agonist. Antiproliferative, antioxidant and anticancer agent with a long half-life in vivo. Apoptotic effects appear to be mediated by a mechanism distinct from that of 'classical' retinoids. Fenretinide: A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent. | monocarboxylic acid amide; retinoid | antineoplastic agent; antioxidant |
ver 155008 | VER 155008: structure in first source | purine nucleoside | |
PF-06446846 | PF-06446846 : A triazolopyridine that is 3H-[1,2,3]triazolo[4,5-b]pyridine substituted by a 4-{(3-chloropyridin-2-yl)[(3R)-piperidin-3-yl]carbamoyl}phenyl group at position 3. It is a potent inhibitor of PCSK9. PF-06446846: inhibits translation of PCSK9 ;structure in first source | benzamides; monochloropyridine; piperidines; tertiary carboxamide; triazolopyridine | antilipemic drug; EC 3.4.21.61 (kexin) inhibitor |